MT-ND4 and ptosis: Symptomatic treatment was also important: patients with ptosis, strabismus, and cataracts can obtain long-term results from surgery [31].Gene (rAAV2-ND4)therapy showed complementary neuroprotective effects in LHON m.1178G > A patients [19, 32].